We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLS
126
DELISTED
Chart Industries
GTLS
$4.35M 0.17%
30,155
-612
-2% -$113K
LRCX icon
127
Lam Research
LRCX
$390B
$4.35M 0.17%
+59,809
New +$4.71M
BAC icon
128
Bank of America
BAC
$442B
$4.33M 0.17%
103,842
-4,311
-4% -$192K
BRBR icon
129
BellRing Brands
BRBR
$1.34B
$4.33M 0.17%
58,164
-795
-1% -$58.4K
IDA icon
130
Idacorp
IDA
$8.2B
$4.32M 0.17%
37,210
+10,954
+42% +$1.23M
AGG icon
131
iShares Core US Aggregate Bond ETF
AGG
$138B
$4.29M 0.17%
43,322
+61
+0.1% +$5.96K
NMIH icon
132
NMI Holdings
NMIH
$3.36B
$4.28M 0.17%
118,606
+446
+0.4% +$16.2K
NSIT icon
133
Insight Enterprises
NSIT
$4.51B
$4.25M 0.17%
28,326
+83
+0.3% +$13.4K
VBTX
134
DELISTED
Veritex Holdings
VBTX
$4.25M 0.17%
170,033
+669
+0.4% +$17.2K
MTSI icon
135
MACOM Technology Solutions
MTSI
$23.7B
$4.23M 0.17%
42,183
-5,645
-12% -$687K
KEX icon
136
Kirby Corp
KEX
$6.93B
$4.23M 0.17%
41,868
+133
+0.3% +$13.9K
REGN icon
137
Regeneron Pharmaceuticals
REGN
$80.8B
$4.19M 0.17%
6,599
-404
-6% -$278K
MTDR icon
138
Matador Resources
MTDR
$6.09B
$4.18M 0.17%
81,759
+16,309
+25% +$901K
ACIW icon
139
ACI Worldwide
ACIW
$5.42B
$4.16M 0.17%
76,015
+24,255
+47% +$1.29M
MGY icon
140
Magnolia Oil & Gas
MGY
$5.94B
$4.15M 0.17%
164,412
+9,343
+6% +$226K
KAI icon
141
Kadant
KAI
$3.99B
$4.14M 0.16%
12,286
+43
+0.4% +$15.6K
INTA icon
142
Intapp
INTA
$2.91B
$4.12M 0.16%
70,549
-1,380
-2% -$91K
DLR icon
143
Digital Realty Trust
DLR
$71.7B
$4.1M 0.16%
28,585
-10,520
-27% -$1.71M
OSW icon
144
OneSpaWorld
OSW
$2.66B
$4.02M 0.16%
239,270
+101,118
+73% +$1.97M
HUBS icon
145
HubSpot
HUBS
$10.5B
$3.97M 0.16%
+6,954
New +$4.88M
MOD icon
146
Modine Manufacturing
MOD
$10.4B
$3.95M 0.16%
51,462
-25,985
-34% -$2.56M
EFSC icon
147
Enterprise Financial Services Corp
EFSC
$2.39B
$3.94M 0.16%
73,252
+276
+0.4% +$15.9K
ENVA icon
148
Enova International
ENVA
$6.29B
$3.88M 0.15%
40,165
+12,397
+45% +$1.28M
LMAT icon
149
LeMaitre Vascular
LMAT
$1.86B
$3.85M 0.15%
45,900
+7,274
+19% +$677K
ANIP icon
150
ANI Pharmaceuticals
ANIP
$1.78B
$3.81M 0.15%
57,074
+761
+1% +$45.5K

Similar funds

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.